[18F]DPA-714 as a biomarker for positron emission tomography imaging of rheumatoid arthritis in an animal model

Arthritis Research and Therapy

Volumn 16, Issue 2, 2014, Pages

  Pottier, Géraldine ^a,b   Bernards, Nicholas ^a,b   Dollé, Frédéric ^b   Boisgard, Raphael ^a,b  

^a INSERM   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; PYRAZOLO [1,5] PYRIMIDINE ACETAMIDE 714 F 18; TRACER; UNCLASSIFIED DRUG; FLUORINE RADIOISOTOPES; N,N-DIETHYL-2-(2-(4-(2-FLUOROETHOXY)PHENYL)-5,7-DIMETHYLPYRAZOLO(1,5-A)PYRIMIDIN-3-YL)ACETAMIDE; PYRAZOLES; PYRIMIDINES; RADIOPHARMACEUTICALS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DARK AGOUTI RAT; DISEASE SEVERITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JOINT SWELLING; MACROPHAGE; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RHEUMATOID ARTHRITIS; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DIAGNOSTIC USE; METHODS; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; RATS; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; FLUORINE RADIOISOTOPES; IMMUNOHISTOCHEMISTRY; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PYRAZOLES; PYRIMIDINES; RADIOPHARMACEUTICALS; RATS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84897501412     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4508     Document Type: Article

References (34)

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010, 376:1094-1108. 10.1016/S0140-6736(10)60826-4, 20870100.
2. Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009, 21:279-283. 10.1097/BOR.0b013e32832a2e16, 2898190, 19318947.
3. Banal F, Dougados M, Combescure C, Gossec L. Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration:a systematic literature review and meta-analysis. Ann Rheum Dis 2009, 68:1184-1191. 10.1136/ard.2008.093187, 18728049.
4. Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, McGonagle D, Pease C, Green MJ, Veale DJ, Isaacs JD, Emery P. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis:a comparison with conventional radiography. Arthritis Rheum 2000, 43:2762-2770. 10.1002/1529-0131(200012)43:12<2762::AID-ANR16>3.0.CO;2-#, 11145034.
5. Perić P, Laktasić-Zerjavić N. The value of sonography and power Doppler in the detection of early arthritis. Reumatizam 2011, 58:94-104.
6. van de Stadt LA, Bos WH, Meursinge Reynders M, Wieringa H, Turkstra F, van der Laken CJ, van Schaardenburg D. The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients:a prospective cohort study. Arthritis Res Ther 2010, 12:R98. 10.1186/ar3028, 2911885, 20487531.
7. Gent YY, Voskuyl AE, Kloet RW, van Schaardenburg D, Hoekstra OS, Dijkmans BA, Lammertsma AA, van der Laken CJ. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis:findings of a prospective pilot study. Arthritis Rheum 2012, 64:62-66. 10.1002/art.30655, 21898356.
8. Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, Tsushima Y, Takagishi K. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford) 2012, 51:1484-1491. 10.1093/rheumatology/kes064, 22513145.
9. Kubota K, Ito K, Morooka M, Minamimoto R, Miyata Y, Yamashita H, Takahashi Y, Mimori A. FDG PET for rheumatoid arthritis:basic considerations and whole-body PET/CT. Ann N Y Acad Sci 2011, 1228:29-38. 10.1111/j.1749-6632.2011.06031.x, 21718320.
10. van der Laken CJ, Elzinga EH, Kropholler MA, Molthoff CF, van der Heijden JW, Maruyama K, Boellaard R, Dijkmans BAC, Lammertsma AA, Voskuy AE. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. Arthritis Rheum 2008, 58:3350-3355. 10.1002/art.23955, 18975347.
11. Polisson RP, Schoenberg OI, Fischman A, Rubin R, Simon LS, Rosenthal D, Palmer WE. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:819-825. 10.1002/art.1780380616, 7779126.
12. Irmler IM, Opfermann T, Gebhardt P, Gajda M, Brauer R, Saluz HP, Kamradt T. In vivo molecular imaging of experimental joint inflammation by combined 18F-FDG positron emission tomography and computed tomography. Arthritis Res Ther 2010, 12:R203. 10.1186/ar3176, 3046507, 21047399.
13. Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, Hart BA, Breedveld FC, Tak PP. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998, 41:1481-1488. 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O, 9704648.
14. Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Smith DE, Kularatne SA, Jansen G, Low PS, Lammertsma AA, van der Laken J. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Arthritis Res Ther 2013, 15:R37. 10.1186/ar4191, 3672671, 23452511.
15. Casellas P, Galiegue S, Basile S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002, 40:475-486. 10.1016/S0197-0186(01)00118-8, 11850104.
16. Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC. Quantitative preclinical imaging of TSPO expression in glioma using N, N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. J Nucl Med 2012, 53:287-294. 10.2967/jnumed.111.095653, 3391587, 22251555.
17. Martín A, Boisgard R, Kassiou M, Dollé F, Tavitian B. Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia:a PET study using [18F]DPA-714. Mol Imaging Biol 2011, 13:10-15. 10.1007/s11307-010-0324-y, 20383592.
18. Hatori A, Yui J, Yamasaki T, Xie L, Kumata K, Fujinaga M, Yoshida Y, Ogawa M, Nengaki N, Kawamura K, Fukumura T, Zhang M-R. PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18kDa). PLoS One 2012, 7:e45065. 10.1371/journal.pone.0045065, 3440397, 22984611.
19. Xie L, Yui J, Hatori A, Yamasaki T, Kumata K, Wakizaka H, Yoshida Y, Fujinaga M, Kawamura K, Zhang M-R. Translocator protein (18kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease. J Hepatol 2012, 57:1076-1082. 10.1016/j.jhep.2012.07.002, 22796156.
20. Chauveau F, Boutin H, Van Camp N, Dollé F, Tavitian B. Nuclear imaging of neuroinflammation:a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 2008, 35:2304-2319. 10.1007/s00259-008-0908-9, 18828015.
21. Dollé F, Luus C, Reynolds A, Kassiou M. Radiolabelled molecules for imaging the translocator protein (18kDa) using positron emission tomography. Curr Med Chem 2009, 16:2899-2923. 10.2174/092986709788803150, 19689272.
22. Roeda D, Kuhnast B, Damont A, Dollé F. Synthesis of fluorine-18-labelled TSPO ligands for imaging neuroinflammation with positron emission tomography. J Fluor Chem 2012, 134:107-114.
23. Damont A, Roeda D, Dollé F. The potential of carbon-11 and fluorine-18 chemistry:illustration through the development of positron emission tomography radioligands targeting the translocator protein 18 kDa. J Labelled Comp Radiopharm 2013, 56:96-104. 10.1002/jlcr.2992, 24285315.
24. Abourbeh G, Thézé B, Maroy R, Dubois A, Brulon V, Fontyn Y, Dollé F, Tavitian B, Boisgard R. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18kDa translocator protein radioligand [18F]DPA-714. J Neurosci 2012, 32:5728-5736. 10.1523/JNEUROSCI.2900-11.2012, 22539835.
25. Winkeler A, Boisgard R, Martin A, Tavitian B. Radioisotopic imaging of neuroinflammation. J Nucl Med 2010, 51:1-4. 10.2967/jnumed.109.065680, 20008995.
26. Chauveau F, Van Camp N, Dollé F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med 2009, 50:468-476. 10.2967/jnumed.108.058669, 19223401.
27. Zheng J, Boisgard R, Siquier-Pernet K, Decaudin D, Dollé F, Tavitian B. Differential expression of the 18kDa translocator protein (TSPO) by neoplastic and inflammatory cells in mouse tumors of breast cancer. Mol Pharm 2011, 8:823-832. 10.1021/mp100433c, 21417480.
28. Winkeler A, Boisgard R, Awde AR, Dubois A, Thézé B, Zheng J, Ciobanu L, Dollé F, Viel T, Jacobs AH, Tavitian B. The translocator protein ligand [18F]DPA-714 images glioma and activated microglia in vivo. Eur J Nucl Med Mol Imaging 2012, 39:811-823. 10.1007/s00259-011-2041-4, 3326235, 22270507.
29. Kropholler M, Boellaard R, Elzinga E, van der Laken C, Maruyama K, Kloet R, Voskuyl A, Dijkmans B, Lammertsma A. Quantification of ( R)-[11C]PK11195 binding in rheumatoid arthritis. Eur J Nucl Med Mol Imaging 2009, 36:624-631. 10.1007/s00259-008-0987-7, 19043704.
30. James ML, Fulton RR, Vercoullie J, Henderson DJ, Garreau L, Chalon S, Dolle F, Costa B, Selleri S, Guilloteau D, Kassiou M. DPA-714, a new translocator protein-specific ligand:synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med 2008, 49:814-822. 10.2967/jnumed.107.046151, 18413395.
31. Damont A, Hinnen F, Kuhnast B, Schöllhorn-Peyronneau M-A, James M, Luus C, Tavitian B, Kassiou M, Dollé F. Radiosynthesis of [18F]DPA-714, a selective radioligand for imaging the translocator protein (18kDa) with PET. J Labelled Comp Radiopharm 2008, 51:286-292.
32. Kuhnast B, Damont A, Hinnen F, Catarina T, Demphel S, Le Helleix S, Coulon C, Goutal S, Gervais P, Dollé F. [18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106-selective radioligands for imaging TSPO 18kDa with PET:automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls. Appl Radiat Isot 2012, 70:489-497. 10.1016/j.apradiso.2011.10.015, 22104496.
33. Cointepas Y, Mangin J-F, Garnero L, Poline J-B, Benali H. BrainVISA:Software platform for visualization and analysis of multi-modality brain data. Neuroimage 2001, 13:S98.
34. Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D'Agostino M-A, Forslind K, Grassi W, Haavardsholm EA, Haugeberg G, Jurik A-G, Landewé RB, Naredo E, O'Connor PJ, Ostendorf B, Potočki K, Schmidt WA, Smolen JS, Sokolovic S, Watt I, Conaghan PG. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013, 72:804-814. 10.1136/annrheumdis-2012-203158, 23520036.